New York, NY -- (SBWIRE) -- 01/31/2013 -- The exploratory talks included parties such as Warner Chilcott Plc. (NASDAQ: WCRX) and Valeant Pharmaceuticals International Inc., according to the sources.
Warner Chilcott is a global specialty pharmaceutical company currently focused on the gastroenterology, women&aposs healthcare, dermatology and urology segments of the U.S. and Western European pharmaceuticals markets. Since being spun out of Warner-Lambert in 1996, Warner Chilcott has evolved, through a series of acquisitions and divestitures, from a small seller of undifferentiated products to a fully integrated pharmaceutical company with a broad portfolio of leading branded products.
Find out more on WCRX here: http://www.monstertradingalerts.com/market-scan/?symbol=WCRX
DARA Biosciences Inc. (NASDAQ: DARA) announced earlier to raise $2.8 million pursuant to Securities Purchase Agreement.
DARA is a specialty pharmaceutical company focused on the development and commercialization of oncology treatment and supportive care products. DARA has comprehensive commercial coverage across the national oncology market through a series of agreements with a number of specialty pharmacy providers, leading group purchasing organizations (GPOs), retail partners, reimbursement experts, and an industry-leading third-party logistics provider.
As part of an integrated national network with annual sales of over $1 billion in cancer therapeutics, DARA has significant commercial scale and capabilities. Its distribution network consists of more than 45,000 retail pharmacies, mail order pharmacies, and long-term care facilities.
Find out more on DARA here: http://www.monstertradingalerts.com/market-scan/?symbol=DARA
MonsterTradingAlerts.com issues momentum alerts on stocks that can provide gains to day traders. MonsterTradingAlerts.com provides members with timely information and exclusive alerts on cheap and under-valued stocks in the United States with the potential to deliver gains of 100% - 200% or more. MonsterTradingAlerts.com monitors and scans the markets for stock related signals as well as any external factors that might bring trading opportunities. Through a vast network of IR professionals MonsterTradingAlerts.com is often in the know of several large investor awareness campaigns being deployed.
Timing is everything when trading Penny Stocks. Gain an Edge by joining the MonsterTradingAlerts.com newsletter and receiving alerts from a Pro-Active team of researchers. Trading Alerts believes traders should have a chance at successfully trading penny stocks and invites traders and investors to be part of the Free VIP membership.
Simply sign up for free and start receiving exclusive alerts.
Subscribe Here: http://www.MonsterTradingAlerts.com
Disclosure: MonsterTradingAlerts.com is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell securities. Investors should always conduct their own due diligence with any potential investment. Please visit MonsterTradingAlerts.com website, for complete risks and disclosures.
Investor Alley, its employees, officers, directors, shareholders and affiliates, hold no positions in the above-mentioned stocks.
Alexander K. Neumann
Monster Trading Alerts
For more information on this press release visit: http://www.sbwire.com/press-releases/pharmaceutical-stocks-traders-should-add-on-top-of-their-watch-list-nasdaq-wcrx-nasdaq-dara-202000.htm
Alexander K. NeumannTelephone: 347-905-5009Email: Click to Email Alexander K. NeumannWeb: http://www.monstertradingalerts.com